Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
Jesús CastillaManuel García CenozRaquel AbadLaura Sánchez-CambroneroNicola LorussoConchita IzquierdoSoledad Cañellas LlabrésJavier RoigAlberto MalvarFernando González CarrilAn L D BooneJaime Pérez MartínM Jesús Rodríguez RecioAntònia GalmésArturo CaballeroAmós García RojasFelipe JuanasMercedes NietoLuis J Viloria RaymundoEva Martínez OchoaAna I RivasDaniel CastrillejoDavid Moreno PérezAna MartínezEva BorràsAmaya Sánchez GómezEliseo PastorVictoria NartalloJosé M ArteagoitiaBlanca Álvarez-FernándezRocío García PinaSocorro Fernández ArribasJoana VanrellSara García HernándezRita M MendozaManuel MéndezM Mar López-TerceroÁngela Fernández-RodríguezÁngela BlancoF Javier Carrillo de AlbornozJosé Ruiz OlivaresRafael Ruiz-MonteroAurora LimiaJosé A Navarro-AlonsoJulio A VázquezAurelio BarricartePublished in: The New England journal of medicine (2023)
Complete vaccination with 4CMenB was found to be effective in preventing invasive disease by serogroup B and non-serogroup B meningococci in children younger than 5 years of age.